| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Rash | |||||
| Non-Small-Cell Lung Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Carcinoma, Non-Small-Cell Lung | |||||
| Exanthema | |||||
| Lung Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Carcinoma | |||||
| Lung Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Neoplasms | |||||
| Skin Diseases | |||||
| Thoracic Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| ACZONE (dapsone) Gel, 5% | |||||
| Vehicle Control | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Dapsone | |||||
| Erlotinib | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Antimalarials | |||||
| Antiparasitic Agents | |||||
| Antiprotozoal Agents | |||||
| Enzyme Inhibitors | |||||
| Folic Acid Antagonists | |||||
| Leprostatic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Protein Kinase Inhibitors | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Allergan | |||||
|
